Lyell Wealth Management LP Has $608,000 Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Lyell Wealth Management LP reduced its holdings in UnitedHealth Group by 65.6%, owning 1,161 shares after selling 2,216 shares, valued at approximately $608,000.
• UnitedHealth recently reported earnings per share of $4.08, missing the expected $4.45, amidst a 12.9% increase in revenue from the previous year.
• The company has announced an increased quarterly dividend of $2.21 per share, up from $2.10, with a yield of 3.5%.

Lyell Wealth Management LP reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 65.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,161 shares of the healthcare conglomerate's stock after selling 2,216 shares during the period. Lyell Wealth Management LP's holdings in UnitedHealth Group were worth $608,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Cordatus Wealth Management LLC lifted its position in UnitedHealth Group by 4.6% during the first quarter. Cordatus Wealth Management LLC now owns 10,706 shares of the healthcare conglomerate's stock valued at $5,607,000 after buying an additional 471 shares in the last quarter. Menard Financial Group LLC boosted its holdings in shares of UnitedHealth Group by 24.7% during the first quarter. Menard Financial Group LLC now owns 4,809 shares of the healthcare conglomerate's stock valued at $2,519,000 after acquiring an additional 953 shares during the period. Hoxton Planning & Management LLC acquired a new stake in UnitedHealth Group in the first quarter worth about $638,000. North Star Asset Management Inc. lifted its holdings in UnitedHealth Group by 3.5% in the first quarter. North Star Asset Management Inc. now owns 25,292 shares of the healthcare conglomerate's stock worth $13,247,000 after purchasing an additional 845 shares during the period. Finally, FSB Premier Wealth Management Inc. lifted its holdings in UnitedHealth Group by 5.8% in the 1st quarter. FSB Premier Wealth Management Inc. now owns 1,935 shares of the healthcare conglomerate's stock valued at $1,014,000 after acquiring an additional 106 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of the firm's stock in a transaction on Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director directly owned 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO John F. Rex acquired 17,175 shares of the firm's stock in a transaction on Friday, May 16th. The stock was purchased at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer owned 203,796 shares in the company, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock worth $31,607,768 in the last three months. 0.28% of the stock is owned by insiders.

UnitedHealth Group Trading Down 4.9%

UNH stock traded down $12.16 during midday trading on Friday, reaching $237.40. The stock had a trading volume of 39,874,177 shares, compared to its average volume of 15,268,949. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The firm has a market cap of $215.36 billion, a price-to-earnings ratio of 10.29, a PEG ratio of 1.56 and a beta of 0.43. The business has a fifty day simple moving average of $296.86 and a two-hundred day simple moving average of $416.24.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the firm earned $6.80 EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.7%. The ex-dividend date of this dividend was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is presently 37.02%.

Wall Street Analyst Weigh In

Several analysts have issued reports on UNH shares. Barclays restated an "overweight" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Truist Financial dropped their price objective on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a report on Wednesday, July 16th. Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Raymond James Financial cut UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Finally, UBS Group restated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $373.52.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.